Veterans with lung cancer may benefit from triple therapy approach

NCT ID NCT06275360

Recruiting now Disease control Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for veterans with stage 3 non-small cell lung cancer that cannot be removed by surgery. It combines chemotherapy, immunotherapy, and radiation to see if this approach helps control the cancer longer and is safe. About 25 participants will receive the treatment, and researchers will track how long the cancer stays under control and any side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

Michael E. DeBakey VA Medical Center, Houston, TX
RECRUITING

Houston, Texas, 77030-4211, United States
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
RECRUITING

Omaha, Nebraska, 68105-1850, United States
Richard L. Roudebush VA Medical Center, Indianapolis, IN
RECRUITING

Indianapolis, Indiana, 46202-2884, United States
Richmond VA Medical Center, Richmond, VA
RECRUITING

Richmond, Virginia, 23249-0001, United States
VA Ann Arbor Healthcare System, Ann Arbor, MI
RECRUITING

Ann Arbor, Michigan, 48105-2303, United States
VA Central Office, Washington, DC
RECRUITING

Washington D.C., District of Columbia, 20420-0001, United States
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
RECRUITING

West Haven, Connecticut, 06516-2770, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.